Search

everythinglearnresearchcommunity

for

Search:↓

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Mollugin may help treat diseases and boost hair growth and anti-aging.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Upadacitinib may cause hair loss.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

New RIPK4 gene mutations were found to cause a type of skin and limb birth defect.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Baricitinib may effectively treat nail changes in alopecia areata.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Cancer treatments often cause skin, nail, and hair problems.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.